Pan Jianyan, Teng Hua, Liu Fang, Chen Siyi, Liu Yaning, Teng Yanling, Liang Desheng, Li Zhuo, Wu Lingqian
Center for Medical Genetics, Hunan Key Laboratory of Medical Genetics, MOE Key Lab of Rare Pediatric Diseases, School of Life Sciences, Central South University, Changsha, 410000, Hunan, China.
Department of Birth Health and Genetics, The Reproductive Hospital of Guangxi Zhuang Autonomous Region, Nanning, 530000, Guangxi, China.
Sci Rep. 2025 Jan 15;15(1):1981. doi: 10.1038/s41598-025-85881-8.
Autosomal dominant deafness-15 which is caused by mutation in the POU4F3 gene, has been reported with a wide degree of clinical heterogeneity, even between intrafamilial members. However, the reason is still elusive. In this study, A four-generation Chinese family with 11 patients manifesting late-onset progressive non-syndromic hearing loss was recruited. The phenotype of hearing loss in this family showed a large variability in terms of onset age and progression speed. A novel mutation (c.706 C > T, p.L236F) was identified by the whole exome sequencing, and its pathogenicity was confirmed by altering the subcellular localization of POU4F3. In addition, we found that two individuals with earlier age of onset and more rapid progression of hearing loss carry additional pathogenic variants in other deafness genes (III-7, STRC:c.4057 C > T; IV-1, GJB2:c.109G > A; CDC14A:c.935G > A). By using the real time quantitative PCR, western blot, luciferase assays and electrophoretic mobility-shift assay, POU4F3 was proved to directly regulate the expression of STRC, GJB2 and CDC14A respectively. ChIP-seq further revealed that POU4F3 can also bind to a series of deafness genes. In summary we expanded the mutation spectrum of POU4F3 by identifying a novel mutation and its pathogenicity. Meanwhile, three genes STRC, GJB2 and CDC14A were validated as POU4F3 new targets, implicating that the variants in the three genes may play a role of genetic modifier to generate a synergistic and enhancement effect on the progression of DFNA15.
常染色体显性遗传性耳聋15型由POU4F3基因突变引起,已有报道称其临床异质性程度广泛,即使在家族内部成员之间也是如此。然而,其原因仍不清楚。在本研究中,招募了一个四代中国家系,其中11名患者表现为迟发性进行性非综合征性听力损失。该家系中听力损失的表型在发病年龄和进展速度方面表现出很大的变异性。通过全外显子组测序鉴定出一个新的突变(c.706 C>T,p.L236F),并通过改变POU4F3的亚细胞定位证实了其致病性。此外,我们发现两名发病年龄较早且听力损失进展较快的个体在其他耳聋基因中携带额外的致病变异(III-7,STR:c.4057 C>T;IV-1,GJB2:c.109G>A;CDC14A:c.935G>A)。通过实时定量PCR、蛋白质印迹法、荧光素酶测定和电泳迁移率变动分析,证明POU4F3分别直接调节STR、GJB2和CDC14A的表达。染色质免疫沉淀测序进一步揭示POU4F3还可以与一系列耳聋基因结合。总之,我们通过鉴定一个新的突变及其致病性扩展了POU4F3的突变谱。同时,验证了三个基因STR、GJB2和CDC14A为POU4F3的新靶点,这意味着这三个基因中的变异可能起到遗传修饰作用,对DFNA15的进展产生协同和增强效应。